search Search

The future of diabetes management is now!​

We live in extraordinary times in diabetes management. Times of technological innovation that make us dream of a not-so-distant future where the risks of type 1 diabetes are minimised and not an impediment for having a healthy baby and a safe pregnancy.

You, as healthcare professional, are a lead character in re-writing the story for many soon-to-be parents!

Advancements in closed-loop diabetes technology

myLoop powered by CamAPS FX is the first hybrid closed-loop algorithm designed and licensed for use during pregnancy.1

Discover myLoop

Clinical evidence shows safety and efficacy

AiDAPT study participants using CamAPS FX algorithm spent +10.5% time in the pregnancy range.1

Read more insights

Endorsement from healthcare systems

In the UK, NICE already recommends hybrid closed-loop systems for any person living with type 1 diabetes planning to get pregnant.2

‘‘There is so much to think about during pregnancy. Once I started trusting the system it felt like I had a weight lifted off my shoulders.’’
Tanya Ilkiw, type 1 diabetes and proud mother of Alyssa
Read Tanya's story

Your guide to help you manage type 1 diabetes and pregnancy when using myLoop

Deep dive into how to counsel and care for women managing their type 1 diabetes when using myLoop hybrid closed-loop at each stage of the pregnancy journey. With the goal of shortening the planning phase, achieving safe pregnancies and deliveries, and caring for healthy mothers for many years to come!

The plan before the plan

About 50% of type 1 diabetes pregnancies are unplanned. Glucose management should be optimised, and safe and effective contraception should be used by all women of childbearing age.3,4

Read the guide
‘‘If you have pump knowledge and CGM knowledge the closed-loop is very straightforward.’’
Endocrinologist participating in AiDAPT study⁵

Shortening the planning​

We discuss type 1 diabetes glycaemic pregnancy targets, therapy management options, results from the AiDAPT study on closed loop, and more!

Read the guide

Redefining Type 1 Diabetes Care in Pregnancy

CamAPS FX is the only hybrid closed-loop app approved for pregnancy, enabling glucose targets as low as 4.4 mmol/L (80 mg/dL). The landmark AiDAPT study showed a +10.5 % improvement in time in the pregnancy-specific target range, fewer complications, and lasting benefits for mothers and babies.

Learn more and download the full article here!
‘‘Before I was on the hybrid closed-loop, every couple of weeks I was having to keep changing all my basal rates to try and keep up, whereas the algorithm just automatically does it.’’
AiDAPT study participant⁶

Healthy and safe pregnancies

Learn all about managing type 1 diabetes with myLoop during pregnancy. With step-by-step guidance for real-life scenarios.​

Read the guide
‘‘HCPs having access to data allowed them to know me, know my body...know what influences what’’
AiDAPT study participant⁶

A happy mother and baby

Post-pregnancy brings new routines and challenges. Find our recommendations for managing type 1 diabetes with myLoop after delivery. 

Read the guide

Why recommend myLoop for pregnancy

The Automated Insulin Delivery (AID) system myLoop is made up of three key elements that communicate with each other: a Continuous Glucose Monitoring (CGM) System, the YpsoPump insulin pump and CamAPS FX, an app-based hybrid closed-loop algorithm.

Discover myLoop

myLoop offers patients in the age of bearing children features specially developed for their needs.

Adaptive and learning

CamAPS FX algorithm adapts insulin delivery based on current and predicted glucose values.

CamAPS FX Personal glucose target screen

Personal glucose target (PGT)

PGT can be set as low as 4.4 mmol/L, matching the needs of women planning pregnancy or pregnant.

"Boost" and "Ease-off"

Use "Boost" and "Ease-off" modes to respond to unexpected fluctuations in insulin sensitivity.

Related Content

You may also be interested in ...

bulb
Product information
myLoop utilizes CamAPS FX, which is indicated for use in children one year of age and older and in pregnancy.
Discover more
phone
Events
Stay informed. Follow us for the latest insights on the most rapidly evolving areas of diabetes technology and treatments.
Follow us
download
Resources
Explore our resources, including detailed factsheets and a variety of downloadable materials, to best support your practice and enhance patient care and professional development.
Explore more

Insulin pumps and Automated Insulin Delivery (AID) systems can greatly improve glucose management but do not eliminate the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g. infusion set failure, pump occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA - even if glucose readings are not very high. DKA is a serious and potentially life-threatening condition.

If you feel unwell, have persistent high glucose levels or detect positive ketones, please immediately contact your diabetes team and follow their advice. Do not rely solely on the AID system to correct high glucose or clear the ketones. Always check that insulin is being delivered and use your backup insulin method (e.g. insulin injections or insulin pens), if needed.

Medical advice can only be provided by healthcare professionals. The information contained in this material is intended for general educational purposes and should not be interpreted as medical advice or used as a substitute for consultation with a qualified healthcare professional.